{"id":"https://openalex.org/W2016058044","doi":"https://doi.org/10.1016/j.jval.2012.08.823","title":"PMH33 Cost Effectiveness of Paliperidone Palmitate Versus Oral Medication in the Treatment of Schizophrenia in Austria","display_name":"PMH33 Cost Effectiveness of Paliperidone Palmitate Versus Oral Medication in the Treatment of Schizophrenia in Austria","publication_year":2012,"publication_date":"2012-10-29","ids":{"openalex":"https://openalex.org/W2016058044","doi":"https://doi.org/10.1016/j.jval.2012.08.823","mag":"2016058044"},"language":"en","primary_location":{"id":"doi:10.1016/j.jval.2012.08.823","doi":"https://doi.org/10.1016/j.jval.2012.08.823","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2012.08.823","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301512025363/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.valueinhealthjournal.com/article/S1098301512025363/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023814743","display_name":"Evelyn Walter","orcid":"https://orcid.org/0000-0003-1533-8912","observed_orcids":["https://orcid.org/0000-0003-1533-8912"]},"institutions":[{"id":"https://openalex.org/I4210163244","display_name":"Institute for Pharmaeconomic Research","ror":"https://ror.org/056whs452","country_code":"AT","type":"facility","lineage":["https://openalex.org/I4210163244"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"E. Walter","raw_affiliation_strings":["Institute for Pharmaeconomic Research, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Pharmaeconomic Research, Vienna, Austria","institution_ids":["https://openalex.org/I4210163244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008693668","display_name":"A. Dragosits","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163244","display_name":"Institute for Pharmaeconomic Research","ror":"https://ror.org/056whs452","country_code":"AT","type":"facility","lineage":["https://openalex.org/I4210163244"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"A. Dragosits","raw_affiliation_strings":["Institute for Pharmaeconomic Research, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Pharmaeconomic Research, Vienna, Austria","institution_ids":["https://openalex.org/I4210163244"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109287526","display_name":"M. Said","orcid":"https://orcid.org/0009-0007-3539-2613","observed_orcids":["https://orcid.org/0009-0007-3539-2613"]},"institutions":[{"id":"https://openalex.org/I4210163244","display_name":"Institute for Pharmaeconomic Research","ror":"https://ror.org/056whs452","country_code":"AT","type":"facility","lineage":["https://openalex.org/I4210163244"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"M. Said","raw_affiliation_strings":["Institute for Pharmaeconomic Research, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Pharmaeconomic Research, Vienna, Austria","institution_ids":["https://openalex.org/I4210163244"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210163244"],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"15","issue":"7","first_page":"A339","last_page":"A340"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.510699987411499,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.510699987411499,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.4812000095844269,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13944","display_name":"Psychiatric care and mental health services","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paliperidone-palmitate","display_name":"paliperidone palmitate","score":0.9769999980926514},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9850000143051147},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9229999780654907},{"id":"https://openalex.org/keywords/oral-antipsychotics","display_name":"oral antipsychotics","score":0.8289999961853027},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.9679999947547913},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":1.0},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.6549999713897705},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.9570000171661377},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.6769999861717224},{"id":"https://openalex.org/keywords/treatment-switching","display_name":"treatment switching","score":0.5049999952316284},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.7580000162124634},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":0.7310000061988831},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.7210000157356262},{"id":"https://openalex.org/keywords/ziprasidone","display_name":"ziprasidone","score":0.9829999804496765},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.7590000033378601},{"id":"https://openalex.org/keywords/markov-model","display_name":"Markov model","score":0.7519999742507935},{"id":"https://openalex.org/keywords/austria","display_name":"Austria","score":0.7310000061988831},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.6000000238418579},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.4880000054836273}],"concepts":[{"id":"https://openalex.org/C2908997079","wikidata":"https://www.wikidata.org/wiki/Q27157250","display_name":"Paliperidone Palmitate","level":4,"score":0.965137243270874},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.8308783769607544},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.7554680705070496},{"id":"https://openalex.org/C2777270317","wikidata":"https://www.wikidata.org/wiki/Q205517","display_name":"Ziprasidone","level":4,"score":0.72925865650177},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.67328941822052},{"id":"https://openalex.org/C2777126507","wikidata":"https://www.wikidata.org/wiki/Q423292","display_name":"Paliperidone","level":4,"score":0.6689938306808472},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5737521052360535},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5421278476715088},{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.48500487208366394},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.47674760222435},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.44469383358955383},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4386191666126251},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.4110088348388672},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.jval.2012.08.823","doi":"https://doi.org/10.1016/j.jval.2012.08.823","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2012.08.823","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301512025363/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.jval.2012.08.823","doi":"https://doi.org/10.1016/j.jval.2012.08.823","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jval.2012.08.823","pdf_url":"http://www.valueinhealthjournal.com/article/S1098301512025363/pdf","source":{"id":"https://openalex.org/S678965","display_name":"Value in Health","issn_l":"1098-3015","issn":["1098-3015","1524-4733"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-a","anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Value in Health","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2016058044.pdf","grobid_xml":"https://content.openalex.org/works/W2016058044.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2095138756","https://openalex.org/W2061159018","https://openalex.org/W2124172687","https://openalex.org/W2145088514","https://openalex.org/W2127061004","https://openalex.org/W1998125234","https://openalex.org/W2765249012","https://openalex.org/W2193166337","https://openalex.org/W2158850341","https://openalex.org/W2344800032"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-07T09:51:55.459714","created_date":"2016-06-24T00:00:00"}